Brian Grabiner

Brian Grabiner has a diverse work experience in the field of neuroscience and drug discovery. Brian is currently serving as the Principal Scientist at Valo since May 2021. Prior to this, they worked at Biogen for six years, holding various roles including Senior Scientist in Human Target Validation and In Vitro Assays, Senior Scientist in Translational Cellular Sciences, and Scientist II in Translational Genomics. In these positions, Brian was responsible for generating in vitro models of neurodegenerative phenotypes, managing collaborations, coordinating work with CROs, and leading technology-driven teams. Before joining Biogen, they were a Postdoctoral Fellow at the Whitehead Institute for seven years. Brian started their career as a Graduate Student at The University of Texas Health Science Center at Houston and previously worked as a Research Technician II at the University at Buffalo.

Brian Grabiner completed their education as follows:

From 1994 to 1997, they attended City Honors High School and earned a Regents Diploma with a focus on General studies.

From 2000 to 2003, they pursued their Bachelor of Science (BS) degree in Biology, General at Buffalo State University.

In 2004, they attended the University at Buffalo and focused on Biology, General. However, the information does not specify if they obtained a degree.

Lastly, from 2005 to 2008, they pursued a Doctor of Philosophy (PhD) in Oncology and Cancer Biology at The University of Texas Health Science Center at Houston (UTHealth Houston).